Beckman Coulter Develops Custom Reagents L.A. Times Archives July 29, 2000 12 AM PT ...

Beckman Coulter Diagnostics is pleased to announce obtaining CE Mark and the release of its new Access TSH (3rd IS) assay for use with the company’s Access Family of Immunoassay Systems.

Available from Beckman Coulter in Europe since 2010, phi will be available in the U.S. in the third quarter of 2012 for use on the company's Access 2 and UniCel DxI immunoassay systems.

PSA and fPSA levels were determined by Access Hybritech PSA and fPSA assays (Beckman Coulter, Fullerton, CA, USA). 22 The immunoassay for the detection of [-2]proPSA was a commercial dual ...

Assay is designed to reduce the need for biopsies in men with PSA levels of 4–10 ng/mL. FDA approved Beckman Coulter’s Prostate Health Index (phi) blood test for detecting prostate cancer in ...

Beckman Coulter Inc. announced that the FDA has approved Prostate Health Index (phi), a non-invasive blood test that is 2.5-times more specific in detecting prostate cancer than PSA (prostate ...

Beckman Coulter Life Sciences launched a family of FormaPure reagent kits for extracting nucleic acid from often challenging formalin-fixed, paraffin-embedded (FFPE) tissues. FormaPure reagent kits ...